{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:06:15Z","timestamp":1792692375061,"version":"4.5.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Aim<\/jats:title><jats:p>We aimed to describe and analyse clinical features, characteristics, and adherence to surveillance guidelines in an Australian Birt-Hogg-Dub\u00e9 syndrome (BHD) and hereditary leiomyomatosis and renal cell cancer (HLRCC) cohort.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>All identified patients with a diagnosis of BHD or HLRCC at RBWH 01\/01\/2014-01\/09\/2019 were included (HREC\/17\/QRBW\/276). All patients were initially assessed and counselled by a clinical geneticist and then referred to an adult nephrologist. Baseline and incidental clinical variables were extracted and analysed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Fifty-seven patients were identified (28 BHD, 29 HLRCC) with a median age of 47 years. The median and cumulative follow-up were 1 and 99 years, respectively. Baseline renal MRI occurred in 40\/57 patients, and 33\/57 had regular MRI as per the national guidelines (eviQ). Of 18\/57 without baseline imaging, nine were yet to have imaging, seven were lost follow-up, and two patients had logistic difficulties. RCC was diagnosed in 11\/57 patients: two of 28 with BHD were diagnosed with RCC aged 73 and 77, both prior to commencement of surveillance. Nine of 29 patients with HLRCC were diagnosed with RCC (one of 29 during surveillance at 47 years of age) and eight of 29 prior to commencement of surveillance (11\u201355 years). Amongst BHD patients, cutaneous fibrofolliculomas were noted in 15 patients, lung cysts were detected in seven patients, spontaneous pneumothoraces in five patients, and parotid oncocytoma in two of 28. Amongst those with HLRCC, cutaneous leiomyomas were noted in 19\/29, cutaneous leiomyosarcoma diagnosed in one of 29, and uterine fibroids in 13 female patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Evidence-based RCC screening in BHD and HLRCC cohort is feasible and able to identify incidental renal lesions. Multidisciplinary patient management enables expedited genetic counselling, diagnosis, longitudinal screening, and RCC management. The success of this clinical model warrants consideration of undertaking longitudinal screening of BHD and HLRCC patients by nephrologists.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2021.738822","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T05:20:51Z","timestamp":1631769651000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Birt-Hogg-Dub\u00e9 Syndrome and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome: An Effective Multidisciplinary Approach to Hereditary Renal Cancer Predisposing Syndromes"],"prefix":"10.3389","volume":"11","author":[{"given":"Mohammad","family":"Al-Shinnag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Marfan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Susman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Wakeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Gustafson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew John","family":"Mallett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2011.04.002","article-title":"Epidemiology of Renal Cell Cancer","volume":"25","author":"Cho","year":"2011","journal-title":"Hematol\/Oncol Clin North Am"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70188-3","article-title":"Birt-Hogg-Dub\u00e9 Syndrome: Diagnosis and Management","volume":"10","author":"Menko","year":"2009","journal-title":"Lancet Oncol"},{"key":"B3","unstructured":""},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nrurol.2015.206","article-title":"Molecular Genetics and Clinical Features of Birt-Hogg-Dub\u00e9 Syndrome","volume":"12","author":"Schmidt","year":"2015","journal-title":"Nat Rev Urol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000154629.45832.30","article-title":"Evaluation and Management of Renal Tumors in the Birt-Hogg-Dub\u00e9 Syndrome","volume":"173","author":"Pavlovich","year":"2005","journal-title":"J Urol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.13457","article-title":"Birt-Hogg-Dub\u00e9 Syndrome: An Underdiagnosed Genetic Tumor Syndrome","volume":"16","author":"Steinlein","year":"2018","journal-title":"J der Deutschen Dermatologischen Gesellschaft = J German Soc Dermatol JDDG"},{"key":"B7","first-page":"393","article-title":"Risk of Renal and Colonic Neoplasms and Spontaneous Pneumothorax in the Birt-Hogg-Dub\u00e9 Syndrome","volume":"11","author":"Zbar","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.463","article-title":"Renal Cancer and Pneumothorax Risk in Birt-Hogg-Dub\u00e9 Syndrome; an Analysis of 115 FLCN Mutation Carriers From 35 BHD Families","volume":"105","author":"Houweling","year":"2011","journal-title":"Br J Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/cas.14255","article-title":"Birt-Hogg-Dub\u00e9 Syndrome-Associated Renal Cell Carcinoma: Histopathological Features and Diagnostic Conundrum","volume":"111","author":"Furuya","year":"2020","journal-title":"Cancer Sci"},{"key":"B10","unstructured":""},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s10689-014-9735-2","article-title":"Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC): Renal Cancer Risk, Surveillance and Treatment","volume":"13","author":"Menko","year":"2014","journal-title":"Familial Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/ng849","article-title":"Germline Mutations in FH Predispose to Dominantly Inherited Uterine Fibroids, Skin Leiomyomata and Papillary Renal Cell Cancer","volume":"30","author":"Tomlinson","year":"2002","journal-title":"Nat Genet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1399-0004.2010.01486.x","article-title":"Hereditary Leiomyomatosis and Renal Cell Cancer in Families Referred for Fumarate Hydratase Germline Mutation Analysis","volume":"79","author":"Smit","year":"2011","journal-title":"Clin Genet"},{"key":"B14","volume-title":"WHO Classification of Tumours of the Urinary System and Male Genital Organs","author":"Moch","year":"2016"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-018-2447-8","article-title":"WHO\/ISUP Classification, Grading and Pathological Staging of Renal Cell Carcinoma: Standards and Controversies","volume":"36","author":"Warren","year":"2018","journal-title":"World J Urol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31804375b8","article-title":"The Morphologic Spectrum of Kidney Tumors in Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC) Syndrome","volume":"31","author":"Merino","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.5694\/mja15.01157","article-title":"A Multidisciplinary Renal Genetics Clinic Improves Patient Diagnosis","volume":"204","author":"Mallett","year":"2016","journal-title":"Med J Aust"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2007.054304","article-title":"BHD Mutations, Clinical and Molecular Genetic Investigations of Birt-Hogg-Dub\u00e9 Syndrome: A New Series of 50 Families and a Review of Published Reports","volume":"45","author":"Toro","year":"2008","journal-title":"J Med Genet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0046-2015","article-title":"Multiple Cystic Lung Disease","volume":"24","author":"Ferreira Francisco","year":"2015","journal-title":"Eur Respir Rev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2009.070565","article-title":"Clinical and Genetic Spectrum of Birt-Hogg-Dube Syndrome Patients in Whom Pneumothorax and\/or Multiple Lung Cysts are the Presenting Feature","volume":"47","author":"Kunogi","year":"2010","journal-title":"J Med Genet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13023-014-0163-z","article-title":"Renal Cell Tumour Characteristics in Patients With the Birt-Hogg-Dub\u00e9 Cancer Susceptibility Syndrome: A Retrospective, Multicentre Study","volume":"9","author":"Benusiglio","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"6265175","DOI":"10.1155\/2018\/6265175","article-title":"Parotid Oncocytoma as a Manifestation of Birt-Hogg-Dub\u00e9 Syndrome","volume":"2018","author":"Yoshida","year":"2018","journal-title":"Case Rep Radiol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.109288","article-title":"Parotid Oncocytoma in the Birt-Hogg-Dub\u00e9 Syndrome","volume":"43","author":"Liu","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2013.8","article-title":"Where Birt-Hogg-Dub\u00e9 Meets Cowden Syndrome: Mirrored Genetic Defects in Two Cases of Syndromic Oncocytic Tumours","volume":"21","author":"Pradella","year":"2013","journal-title":"Eur J Hum Genet EJHG"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2010.01480.x","article-title":"Constitutional FLCN Mutations in Patients With Suspected Birt-Hogg-Dub\u00e9 Syndrome Ascertained for non-Cutaneous Manifestations","volume":"79","author":"Maff\u00e9","year":"2011","journal-title":"Clin Genet"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2019.11.002","article-title":"Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals","volume":"3","author":"Forde","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/cge.13014","article-title":"Reassessing the Clinical Spectrum Associated With Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome in French FH Mutation Carriers","volume":"92","author":"Muller","year":"2017","journal-title":"Clin Genet"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.051633798","article-title":"Inherited Susceptibility to Uterine Leiomyomas and Renal Cell Cancer","volume":"98","author":"Launonen","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2015.02.004","article-title":"Reed Syndrome Presenting With Leiomyosarcoma","volume":"1","author":"Wang","year":"2015","journal-title":"JAAD Case Rep"},{"key":"B30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1086\/376435","article-title":"Mutations in the Fumarate Hydratase Gene Cause Hereditary Leiomyomatosis and Renal Cell Cancer in Families in North America","volume":"73","author":"Toro","year":"2003","journal-title":"Am J Hum Genet"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000617","article-title":"Fumarate Hydratase-Deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome","volume":"40","author":"Trpkov","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4314\/pamj.v9i1.71195","article-title":"The Effect of Multidisciplinary Team Care on Cancer Management","volume":"9","author":"Abdulrahman","year":"2011","journal-title":"Pan Afr Med J"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2009.04.008","article-title":"A Multidisciplinary Approach to the Management of Urologic Malignancies: Does it Influence Diagnostic and Treatment Decisions","volume":"29","author":"Kurpad","year":"2011","journal-title":"Urol Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015121335","article-title":"The Nephrologist's Tumor: Basic Biology and Management of Renal Cell Carcinoma","volume":"27","author":"Hu","year":"2016","journal-title":"J Am Soc Nephrol JASN"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2018.10","article-title":"The Role of Nephrologists in the Management of Small Renal Masses","volume":"14","author":"Hu","year":"2018","journal-title":"Nat Rev Nephrol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.738822\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T05:20:55Z","timestamp":1631769655000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.738822\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,16]]},"references-count":35,"alternative-id":["10.3389\/fonc.2021.738822"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.738822","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,16]]},"article-number":"738822"}}